PHATHOM PHARMACEUTICALS INC's ticker is PHAT and the CUSIP is 71722W107. A total of 85 filers reported holding PHATHOM PHARMACEUTICALS INC in Q3 2021. The put-call ratio across all filers is - and the average weighting 0.6%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2022 | $2,838,000 | -38.0% | 336,223 | 0.0% | 0.06% | -15.3% |
Q1 2022 | $4,576,000 | -30.8% | 336,223 | 0.0% | 0.07% | -15.3% |
Q4 2021 | $6,614,000 | -65.7% | 336,223 | -44.0% | 0.08% | -66.5% |
Q3 2021 | $19,260,000 | -5.2% | 600,000 | 0.0% | 0.25% | -7.0% |
Q2 2021 | $20,310,000 | -9.9% | 600,000 | 0.0% | 0.27% | -18.3% |
Q1 2021 | $22,536,000 | +13.1% | 600,000 | 0.0% | 0.33% | +9.2% |
Q4 2020 | $19,932,000 | +20.8% | 600,000 | +33.3% | 0.31% | -5.3% |
Q3 2020 | $16,502,000 | +11.4% | 450,000 | 0.0% | 0.32% | +0.3% |
Q2 2020 | $14,809,000 | +27.5% | 450,000 | 0.0% | 0.32% | -14.4% |
Q1 2020 | $11,619,000 | -17.1% | 450,000 | 0.0% | 0.38% | -4.8% |
Q4 2019 | $14,013,000 | – | 450,000 | – | 0.40% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Medicxi Ventures Management (Jersey) Ltd | 3,760,869 | $39,000,212 | 12.45% |
Frazier Life Sciences Management, L.P. | 10,109,279 | $104,833,223 | 6.96% |
Decheng Capital Management III (Cayman), LLC | 850,000 | $8,814,500 | 2.94% |
Carlyle Group Inc. | 3,496,808 | $36,191,963 | 1.57% |
Ghost Tree Capital, LLC | 395,000 | $4,096,150 | 1.35% |
Newtyn Management, LLC | 500,000 | $5,185,000 | 1.28% |
Altium Capital Management LP | 220,000 | $2,281,400 | 1.19% |
StepStone Group LP | 422,085 | $4,377,021 | 0.98% |
MPM BioImpact LLC | 347,332 | $3,601,833 | 0.96% |
NEA Management Company, LLC | 1,276,595 | $12,238,290 | 0.94% |